These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26196246)

  • 1. Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma.
    Chen CY; Lin YS; Chen CL; Chao PZ; Chiou JF; Kuo CC; Lee FP; Lin YF; Sung YH; Lin YT; Li CF; Chen YJ; Chen CH
    Oncotarget; 2015 Sep; 6(29):26946-59. PubMed ID: 26196246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma.
    Chen CY; Lin YS; Chen CH; Chen YJ
    J Biomed Sci; 2018 Mar; 25(1):30. PubMed ID: 29598816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells respond to nasopharygeal carcinoma cells through annexin A2-recognizing DC-SIGN.
    Chao PZ; Hsieh MS; Cheng CW; Hsu TJ; Lin YT; Lai CH; Liao CC; Chen WY; Leung TK; Lee FP; Lin YF; Chen CH
    Oncotarget; 2015 Jan; 6(1):159-70. PubMed ID: 25402728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein.
    Lu X; Mei Y; Fan C; Chen P; Li X; Zeng Z; Li G; Xiong W; Xiang B; Yi M
    Cell Oncol (Dordr); 2024 Jun; 47(3):833-850. PubMed ID: 37962808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF19 promotes nasopharyngeal carcinoma progression by inducing angiogenesis via inhibiting TRIM21-mediated ANXA2 ubiquitination.
    Shi S; Zhang Q; Zhang K; Chen W; Xie H; Pan S; Xue Z; You B; Zhao J; You Y
    Cell Oncol (Dordr); 2024 Feb; 47(1):283-301. PubMed ID: 37782406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of Annexin A2 expression in oral squamous cell carcinoma and its influence on cell proliferation, migration and invasion.
    Ma Y; Wang H
    Sci Rep; 2021 Mar; 11(1):5033. PubMed ID: 33658625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A2 in renal cell carcinoma: expression, function, and prognostic significance.
    Yang SF; Hsu HL; Chao TK; Hsiao CJ; Lin YF; Cheng CW
    Urol Oncol; 2015 Jan; 33(1):22.e11-22.e21. PubMed ID: 25284003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
    Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
    J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells.
    Zhang HJ; Yao DF; Yao M; Huang H; Wang L; Yan MJ; Yan XD; Gu X; Wu W; Lu SL
    World J Gastroenterol; 2013 Jun; 19(24):3792-801. PubMed ID: 23840117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling.
    Yi Y; Zeng S; Wang Z; Wu M; Ma Y; Ye X; Zhang B; Liu H
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):793-803. PubMed ID: 29253515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
    Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R
    Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
    Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
    Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
    Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
    J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma.
    Lu Y; Liang Y; Zheng X; Deng X; Huang W; Zhang G
    J Exp Clin Cancer Res; 2019 Feb; 38(1):82. PubMed ID: 30770775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
    Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
    Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
    Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B
    Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Junctional adhesion molecule-A, an epithelial-mesenchymal transition inducer, correlates with metastasis and poor prognosis in human nasopharyngeal cancer.
    Tian Y; Tian Y; Zhang W; Wei F; Yang J; Luo X; Zhou T; Hou B; Qian S; Deng X; Qiu Y; Yao K
    Carcinogenesis; 2015 Jan; 36(1):41-8. PubMed ID: 25416560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of Annexin A2 gene transcription down-regulation on human hepatoma cell biological behaviour].
    Zhang H; Yao M; Qian Q; Shi Y; Li J; Chen X; Wang S; Yao D
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):620-4. PubMed ID: 25243965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.
    Bystricky B; Cierna Z; Sieberova G; Janega P; Karaba M; Minarik G; Benca J; Sedlackova T; Jurisova S; Gronesova P; Pindak D; Macuch J; Mardiak J; Mego M
    Anticancer Res; 2017 May; 37(5):2727-2734. PubMed ID: 28476852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.